Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Canto e Castro, Luísa ; Pereira, Ana Helena Guia ; Ribeiro, Rita ; Alves, Catarina ; Veloso, Luís ; Vicente, Vera ; Alves, Dalila ; Domingues, Inês ; Silva, Cláudia ; Gomes, Andreia ; Serrano, Marta ; Afonso, Ângela ; Veldhoen, Marc ; de Sousa, Maria José Rego ; de Sousa, José Germano Rego ; de Sousa, Germano ; Mota, Maria M. ; Silva-Santos, Bruno ; Ribeiro, Ruy M.
• Description:
  In September 2020, we tested 13,398 persons in Portugal for antibodies against severe acute respiratory syndrome coronavirus 2 by using a quota sample stratified by age and population density. We found a seroprevalence of 2.2%, 3-4 times larger than the official number of cases at the end of the first wave of the pandemic.
• Subjects:
  Coronavirus Infections Covid-19 Humans Pandemics Prevalence Sars-Cov-2 Seroepidemiologic Studies
• Source:
  Emerg Infect Dis. 27(11):2878-2881
• Pubmed ID:
  34437830
• Pubmed Central ID:
  PMC8544986
• Document Type:
  Journal Article
• Place as Subject:
  Portugal
• Volume:
  27
• Issue:
  11
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:19ce80ee5330bf1c9001723295fa1e1bc9e75025eed2b89c0949c9f55f9d4850
• Download URL:
  https://stacks.cdc.gov/view/cdc/111435/cdc_111435_DS1.pdf
• File Type:
  [PDF - 831.56 KB ]